Paper Details
- Home
- Paper Details
Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment.
Author: CamiciPaolo G, CreaFilippo, DanchinNicolas, FerrariRoberto, FoxKim, Lopez-SendonJosé, ManolisAthanasios, MarzilliMario, PavasiniRita, PintoFausto, RosanoGiuseppe M C
Original Abstract of the Article :
Chronic stable angina is the most prevalent symptom of ischaemic heart disease and its management is a priority. Current guidelines recommend pharmacological therapy with drugs classified as being first line (beta blockers, calcium channel blockers, short acting nitrates) or second line (long-acting...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1093/eurheartj/ehy504
データ提供:米国国立医学図書館(NLM)
The Quest for the Perfect Anti-Anginal Drug
As a seasoned researcher, I've spent countless hours poring over medical texts, much like a camel traversing a vast desert of knowledge. In the realm of cardiovascular medicine, the search for effective anti-anginal drugs is a perpetual pursuit. This particular research digs deep into the evidence surrounding these drugs, spanning a remarkable 50-year period. The authors, like intrepid explorers, embark on a systematic review, meticulously examining the outcomes of numerous clinical trials. Their findings? Well, let's just say it's a bit of a head-scratcher!A Curious Case of Equivalence
The study reveals that while several classes of anti-anginal drugs have been extensively studied, there's no clear-cut winner. It's like comparing different types of oasis in the desert – each offers sustenance but none truly stands out as the ultimate haven. Interestingly, equivalence was demonstrated for beta-blockers, calcium antagonists, and channel inhibitors in three of the studies. Imagine this: you're in the desert, thirsty, and you come across three equally refreshing oases. You might choose one based on its location or aesthetic appeal, but ultimately, they all quench your thirst.Navigating the Desert of Angina
While the research uncovers the lack of a superior anti-anginal drug, it does highlight the importance of individual needs and preferences. Think of it this way: in the vast desert of angina, there are various paths to navigate. One path might be better suited for a camel caravan while another might be more suitable for a lone traveler. Ultimately, the best treatment plan is the one that works best for the individual patient.Dr.Camel's Conclusion
This research serves as a reminder that the search for a single, perfect solution in medicine is often an elusive pursuit. Instead, it emphasizes the importance of individualized care and a nuanced understanding of the complex interplay between different treatment options. In the vast and often unpredictable desert of medical research, we must keep exploring, seeking to understand the unique needs of each patient.Date :
- Date Completed 2020-07-13
- Date Revised 2021-04-01
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.